Activities of telithromycin, erythromycin, fluoroquinolones, and doxycycline against Campylobacter strains isolated from Finnish subjects

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 3, 2006, Pages 1086-1088

  Schönberg Norio, Daniela ^a   Hänninen, Marja Liisa ^a   Katila, Marja Leena ^b   Kaukoranta, Suvi Sirkku ^c,i   Koskela, Markku ^d   Eerola, Erkki ^e   Uksila, Jaakko ^f   Pajarre, Sini ^g   Rautelin, Hilpi ^a,h  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c NORTH KARELIA CENTRAL HOSPITAL   (Finland)

^d OULU UNIVERSITY HOSPITAL   (Finland)

^e UNIVERSITY OF TURKU   (Finland)

^f Central Finland Central Hospital   (Finland)

^g SATAKUNTA CENTRAL HOSPITAL   (Finland)

^h UNIVERSITY OF HELSINKI   (Finland)

ⁱ VAASA CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; DOXYCYCLINE; ERYTHROMYCIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TELITHROMYCIN;

ANTIMICROBIAL ACTIVITY; ARTICLE; CAMPYLOBACTER; CAMPYLOBACTER COLI; CAMPYLOBACTER JEJUNI; CONTROLLED STUDY; FINLAND; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; INFECTION SENSITIVITY; ISOLATION PROCEDURE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STRAIN IDENTIFICATION;

ANTI-BACTERIAL AGENTS; CAMPYLOBACTER; DOXYCYCLINE; ERYTHROMYCIN; FINLAND; FLUOROQUINOLONES; HUMANS; KETOLIDES; MICROBIAL SENSITIVITY TESTS;

EID: 33644654449     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.50.3.1086-1088.2006     Document Type: Article

References (21)

1. Aarestrup, F., E. Nielsen, M. Madsen, and J. Engberg. 1997. Antimicrobial susceptibility patterns of thermophilic Campylobacter spp. from humans, pigs, cattle, and broilers in Denmark. Antimicrob. Agents Chemother. 41:2244-2250.
2. Commonwealth of Australia. 1999. The use of antibiotics in food-producing animals: antibiotic-resistant bacteria in animals and humans. Report of the Joint Expert Technical Advisory Committee on Antibiotic Resistance (JETACAR). [Online.] http://www.health.gov.au/pubs/jetacar.htm.
3. Endtz, H., G. Ruijs, B. van Klingeren, W. Jansen, T. van der Reyden, and P. Mouton. 1991. Quinolone resistance in campylobacter isolated from man and poultry following the introduction of fluoroquinolones in veterinary medicine. J. Antimicrob. Chemother. 27:199-208.
4. Engberg, J., F. Aarestrup, D. Taylor, P. Gerner-Smidt, and I. Nachamkin. 2001. Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates. Emerg. Infect. Dis. 7:24-34.
5. Engberg, J., J. Neimann, E. Nielsen, F. Aarestrup, and V. Fussing. 2004. Quinolone-resistant Campylobacter infections: risk factors and clinical consequences. Emerg. Infect. Dis. 10:1056-1063.
6. Felmingham, D., and D. Farrell. 2005. In vitro activity of tclithromycin against Gram-negative bacterial pathogens. J. Infect. [Online.] doi:10.1016/j.jinf.2005.05 .014.
7. Hakanen, A., M. Lehtopolku, A. Siitonen, P. Huovinen, and P. Kotilainen. 2003. Multidrug resistance in Campylobacter jejuni strains collected from Finnish patients during 1995-2000. J. Antimicrob. Chemother. 52:1035-1039.
8. Hoge, C., J. Gambel, A. Srijan, C. Pitarangsi, and P. Echeverria. 1998. Trends in antibiotic resistance among diarrheal pathogens isolated in Thailand over 15 years. Clin. Infect. Dis. 26:341-345.
9. Li, C.-C., C.-H. Chiu, J.-L. Wu, Y.-C. Huang, and T.-Y. Lin. 1998. Antimicrobial susceptibilities of Campylobacter jejuni and coli by using E-test in Taiwan. Scand. J. Infect. Dis. 30:39-42.
10. McDermott, P., S. Bodeis, F. Aarestrup, S. Brown, M. Traczewski, P. Fedorka-Cray, M. Wallace, I. Critchley, C. Thornsberry, S. Graff, R. Flamm, J. Beyer, D. Shortridge, L. Piddock, V. Ricci, M. Johnson, R. Jones, B. Reller, S. Mirrett, J. Aldrobi, R. Rennie, C. Brosnikoff, L. Turnbull, G. Stein, S. Schooley, R. Hanson, and R. Walker. 2004. Development of a standardized susceptibility test for Campylobacter with quality-control ranges for ciprofloxacin, doxycycline, erythromycin, gentamicin, and meropenem. Microb. Drug Resist. 10:124-131.
11. Myllyniemi, A.-L., J. Koppinen, V. Gindonis, and S. Nykäsenoja. 2005. FINRES-Vet 2002-2003, Finnish Veterinary Antimicrobial Resistance Monitoring and Consumption of Antimicrobial Agents. National Veterinary and Food Research Institute (EELA), Helsinki, Finland. [Online.] http://www .eela.fi/linked/fi/julkaisut/finres_vet.pdf.
12. National Committee for Clinical Laboratory Standards. 2003. Informational supplement M100-S13. NCCLS, Wayne, Pa.
13. Rautelin, H., A. Vierikko, M.-L. Hänninen, and M. Vaara. 2003. Antimicrobial susceptibilities of Campylobacter strains isolated from Finnish subjects infected domestically or from those infected abroad. Antimicrob. Agents Chemother. 47:102-105.
14. Rautelin, H. and M.-L. Hänninen. 2000. Campylobacters: the most common bacterial enteropathogens in the Nordic countries. Ann. Med. 32:440-445.
15. Rautelin, H., O.-V. Renkonen, and T. Kosunen. 1991. Emergence of fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli in subjects from Finland. Antimicrob. Agents Chemother. 35:2065-2069.
16. Reina, J., M. Ros, and A. Serra. 1994. Susceptibilities to 10 antimicrobial agents of 1220 Campylobacter strains isolated from 1987 to 1993 from feces of pediatric patients. Antimicrob. Agents Chemother. 38:2917-2920.
17. Sánchez, R., V. Fernández-Baca, M. Díaz, P. Munoz, M. Rodríguez-Créixems, and E. Bouza. 1994. Evolution of susceptibilities of Campylobacter spp. to quinolones and macrolides. Antimicrob. Agents Chemother. 38:1879-1882.
18. Sjögren, E., G.-B. Lindblom, and B. Kaijser. 1997. Norfloxacin resistance in Campylobacter jejuni and Campylobacter coli isolates from Swedish patients. J. Antimicrob. Chemother. 40:257-261.
19. Smith, K., J. Besser, C. Hedberg, F. Leano, J. Bender, J. Wicklund, B. Johnson, K. Moore, and M. Österholm. 1999. Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-1999. N. Engl. J. Med. 340:1525-1532.
20. Unicomb, L., J. Ferguson, T. Riley, and P. Collignon. 2003. Fluoroquinolone resistance in campylobacter absent from isolates, Australia. Emerg. Infect. Dis. 9:1482-1483.
21. Van Looveren, M., G. Daube, L. de Zutter, J.-M. Dumont, C. Lammens, M. Wijdooghe, P. Vandamme, M. Jouret, M. Cornelius, and H. Goossens. 2001. Antimicrobial susceptibilities of Campylobacter strains isolated from food animals from Belgium. J. Antimicrob. Chemother. 48:235-240.